Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders
Scientists have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.
http://dlvr.it/SQm7h4
http://dlvr.it/SQm7h4
Yorumlar
Yorum Gönder